Sign In

Andrew Hardy

Senior Director, Strategy & Corporate Development at CSL Behring

Professional Background

Andrew Hardy is an accomplished professional with a distinguished career spanning academia and the biopharmaceutical industry. A proven strategic thinker, Andrew expertly integrates qualitative and quantitative data to enhance decision-making processes in diverse global environments, focusing on various therapeutic and functional areas. His expertise lends itself particularly well to translational medicine and alliance management, showcasing a robust ability to navigate the complexities of corporate and clinical settings.

Previously, Andrew served as the Senior Director of Strategy and Corporate Development at CSL Behring. In this capacity, he played an integral role in shaping the strategic vision of the company, guiding initiatives that impacted the company's long-term growth and fostered successful corporate transformations. His journey at CSL Behring began with roles in business development where he ascended from Senior Manager to Director, further solidifying his expertise in nurturing partnerships and driving strategic initiatives.

Before joining CSL Behring, Andrew made significant contributions to The Children's Hospital of Philadelphia, where he held key roles such as Interim Co-Director of the Office of Technology Transfer and Licensing Associate. His work at the hospital highlighted his proficiency in technology transfer and the commercialization of groundbreaking medical innovations, demonstrating his keen ability to identify opportunities that bridge research and practical application.

Andrew's early career laid a strong foundation in scientific research, having worked as a Senior Research Associate at Vitae Pharmaceuticals, and as a Biologist at the National Cancer Institute. These roles entrenched him deeply in the world of scientific inquiry and discovery, equipping him with a thorough understanding of the research and development process that underpins the biopharmaceutical field.

Education and Achievements

Andrew's educational background is as impressive as his professional journey. He holds a Bachelor of Arts degree in Natural Sciences and Public Health from The Johns Hopkins University, one of the leading institutions renowned for its research and public health contributions. This foundational knowledge equipped him with a nuanced understanding of health-related issues and provided him with robust analytical skills.

To further enhance his expertise in the business aspects of the health sector, Andrew pursued an MBA from the University of Florida's Warrington College of Business. This degree enabled him to merge his scientific understanding with business acumen, allowing him to approach complex health challenges with a strategic mindset.

In a quest for advanced scientific knowledge, Andrew earned a Master of Science in Medical Sciences from the University of Florida College of Medicine. This program deepened his understanding of medical research and its applications in clinical practice, providing him with the scientific rigor needed for his subsequent roles in the biopharmaceutical industry.

Andrew's education, combined with his extensive experience, positions him as a leader in strategy and corporate development within the biopharmaceutical sector. His ability to leverage insights from diverse fields showcases his adaptability and foresight, further enhancing his reputation as a key player in shaping the future of health solutions.

Notable Achievements

Throughout his career, Andrew Hardy has cultivated a series of noteworthy accomplishments that reflect his commitment to excellence and innovation. His strategic insights have led to the successful navigation of complex transactions and the establishment of fruitful alliances across various therapeutic areas, significantly impacting the organizations he has served.

At CSL Behring, his leadership in strategy development was pivotal in driving growth and establishing the company's presence in highly competitive markets. Andrew’s work has not only contributed to the company’s bottom line but has also played a crucial role in delivering essential therapies to patients in need.

As a thought leader in translational medicine, Andrew has contributed to advancing the bridge between scientific discovery and therapeutic application. His experience in technology transfer at The Children's Hospital of Philadelphia has fostered innovative partnerships that catalyze the movement of novel research findings into viable treatment options.

Furthermore, his scientific rigor and strategic mindset have made him a mentor and an invaluable resource for aspiring professionals in the field. Andrew’s ability to synthesize complex data into impactful strategies is a hallmark of his career, ensuring that he remains at the forefront of advancements in the biopharmaceutical landscape.

tags':['strategic thinker','biopharmaceutical industry','translational medicine','alliance management','CSL Behring','The Children’s Hospital of Philadelphia','technology transfer','public health','biotechnology','research and development'],

questions':['How did Andrew Hardy develop his expertise in corporate strategy within the biopharmaceutical sector?','What insights can Andrew Hardy share about the role of technology transfer in advancing medical research?','How has Andrew Hardy’s education at Johns Hopkins University influenced his career in public health and strategic development?','What key strategies has Andrew Hardy implemented at CSL Behring to drive corporate growth?','In what ways has Andrew Hardy’s experience at The Children’s Hospital of Philadelphia impacted his approach to biopharmaceutical partnerships?']}} idence to showcase his comprehensiveness and adaptability in various aspects of biomedical science and health policy.

Andrew Hardy
Add to my network

Location

Greater Philadelphia